Martlet Capital

Investor type


Last fund created





United Kingdom

$0-1 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy


Martlet Capital Limited has invested in more than 50 start-ups, since its launch in 2011. We provide patient capital for early-stage IP rich, B2B deep technology and life science start-ups, with a primary focus on companies based in Cambridge. Our team is comprised of experienced investors and entrepreneurs. Initial sums of capital of £250K are invested to help support early-stage companies. Martlet will almost always co-invest with angels and seed funds and has the capacity to follow on in subsequent investment rounds. In addition to capital, we offer support, experience and a network of contacts. Martlet typically focuses on pre-seed and seed-stage companies. Potential investees must demonstrate their potential for rapid growth and will usually possess a strong defensible position with respect to their technology, intellectual property and products. In all cases, there must be a strong and demonstratable commercial demand for the technology under development. We have achieved several exits from our portfolio, from trade sales to global technology companies and IPO’s. Please visit our website to learn more.


Business Services (B2B) Construction Healthcare Services Industrial IT Services Media and Entertainment Other Robotics SaaS Software Telecommunications Blockchain/Crypto AI Technology Life Sciences Energy PropTech / ConTech VR/AR HealthTech Mobility MedTech Deeptech

Region of investment



Upgrade to see contacts
FP5ZvUwofBQHmLY9 Martlet Capital
Martlet Capital
FP5ZvUwofBQHmLY9 Investment Directo
Investment Directo
FP5ZvUwofBQHmLY9 Investment Analyst
Investment Analyst
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!